JPMorgan (JPM) stock price jumps nearly 4% as Dow tops 50,000 — what to watch before Monday’s open
8 February 2026
2 mins read

JPMorgan (JPM) stock price jumps nearly 4% as Dow tops 50,000 — what to watch before Monday’s open

New York, Feb 8, 2026, 10:10 (EST) — The session has wrapped up; trading is finished for the day.

• JPMorgan climbed roughly 4% on Friday, wrapping up near $322.
• That gain tracked a wider U.S. rally, with the Dow crossing 50,000.
• Focus shifts this week to U.S. jobs and inflation numbers, plus JPMorgan’s Feb. 23 update.

JPMorgan Chase & Co. finished Friday at $322.40, up 3.9%. Shares moved between $309.79 and $324.20 during the session. Roughly 17.8 million shares changed hands.

The Dow Jones Industrial Average broke through 50,000 for the first time ever, closing at a record high and highlighting momentum that’s now stretching beyond mega-cap tech stocks. “What’s driven it recently has been the broadening … other than just the tech, AI trade,” said Chuck Carlson, chief executive officer at Horizon Investment Services. 1

JPMorgan shareholders are watching rates—again—as the main catalyst. The U.S. Bureau of Labor Statistics marks Feb. 11 for the Employment Situation report, with consumer price index numbers coming Feb. 13. Big releases for Treasury yields and Fed policy wagers. 2

Chipmakers roared back Friday, fueling a rally in U.S. stocks as renewed appetite for AI infrastructure spending from major cloud companies took center stage. “There’s real demand for AI products,” said Ross Mayfield, investment strategy analyst at Baird. He called it a market where buyers reliably step in on pronounced selloffs. 3

Banks moved up alongside the wider market. Bank of America advanced 2.9% Friday, while Wells Fargo added 2.6%. Other lenders climbed as well. 4

New numbers offered a bit of a boost for the banks. Consumer sentiment in the U.S. climbed to its highest level in half a year, according to a University of Michigan survey out early February, but worries around jobs and inflation tied to tariffs didn’t go away. JPMorgan and other consumer lenders are watching these signals closely—confidence and steady paychecks drive card activity, delinquencies, and appetite for credit. 5

Yet, policy uncertainty lingers. While the White House’s 10% credit-card rate cap initiative has hit a wall in Congress, card issuers are still churning out solid numbers, according to The Wall Street Journal. But the headline risk isn’t going anywhere for banks with big card businesses. 6

Mark Feb. 23: JPMorgan has scheduled a company update in New York. The bank plans to offer a firm overview, with executive management fielding questions during Q&A sessions. 7

How rates shift probably shapes trading until then. Friday’s close saw the 10-year U.S. Treasury yield land at 4.22%, with the 2-year at 3.50%. If long-term yields keep dropping, bank margins feel the pinch; a sharp jump, though, can squeeze financial conditions and stoke concerns about credit losses ahead. 8

When the bell rings Monday, JPMorgan will be watching bonds and eyeing any signs that cash keeps shifting into cyclical names. The next set of key data drops midweek: jobs numbers hit Feb. 11, then CPI on Feb. 13—both ahead of JPMorgan’s update scheduled for Feb. 23 in New York.

Stock Market Today

Exxon stock at $149: oil headlines and a dividend date set the next test

Exxon stock at $149: oil headlines and a dividend date set the next test

8 February 2026
Exxon Mobil shares closed up 2.0% at $149.05 Friday, near the session high, as oil prices rose on U.S.-Iran tensions. The Dow ended above 50,000 for the first time and the S&P 500 energy sector hit a record. Exxon’s Feb. 12 shareholder record date approaches for its March dividend. U.S. markets reopen Monday.
Eli Lilly stock: what to watch Monday after FDA pressure forces Hims to pull a weight-loss pill

Eli Lilly stock: what to watch Monday after FDA pressure forces Hims to pull a weight-loss pill

8 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after Hims & Hers said it would halt sales of a compounded weight-loss pill following an FDA warning. U.S. regulators said they will crack down on mass-marketed, non-approved GLP-1 drugs. The FDA threatened legal action against violators and referred Hims to the Justice Department. Investors are watching for enforcement impact on obesity-drug pricing.
Eli Lilly stock: what to watch Monday after FDA pressure forces Hims to pull a weight-loss pill
Previous Story

Eli Lilly stock: what to watch Monday after FDA pressure forces Hims to pull a weight-loss pill

Exxon stock at $149: oil headlines and a dividend date set the next test
Next Story

Exxon stock at $149: oil headlines and a dividend date set the next test

Go toTop